pertuzumab
roche
['mbc', 'pertuzumab']
suggestion of improved os with pertuzumab rechallenge for her2+ mbc in the jbcrg-m05 precious phase 3 trial, despite negative pfs data. highly intriguing, and worth further study. #asco23 
Medical Oncologist, Research Fellow @DanaFarber | @Harvard | PhD @LaStatale | former @IEOufficiale. Interested in breast oncology, HER2, ADCs & good music.